Understanding Dynamics of Pandemics: Turkish Journal of Medical Sciences
Understanding Dynamics of Pandemics: Turkish Journal of Medical Sciences
Understanding Dynamics of Pandemics: Turkish Journal of Medical Sciences
Abstract: Along the centuries, novel strain of virus such as influenza produces pandemics which increase illness, death and
disruption in the countries. Spanish flu in 1918, Asian flu in 1957, Hong Kong flu in 1968 and swine flu in 2009 were known
pandemic which had various characteristics in terms of morbidity and mortality. A current pandemic is caused by novel corona virus
originated from China. COVID-19 pandemic is very similar to Spanish, Hong Kong, Asian and swine influenza pandemics in
terms of spreading to world by the mobilized people. Burden of pandemic is considered in terms of disease transmissibility and the
growth rate of epidemic and duration of pandemic can be calculated by transmissibility characteristic. The case definition, finding
out cases and first case cluster, proper treatment, sufficient stockpiles of medicine and population cooperation with the containment
strategy should be considered for reduction of burden of pandemic.
516 516
AKIN and GÖZEL / Turk J Med
2 Sci (2005). The threat of pandemic influenza: are we ready? chapter 1: the story
Institute of Medicine of the National Academies
of influenza [online]. Website https://www.ncbi.nlm.nih.gov/books/NBK22156/pdf/Bookshelf_NBK22156.pdf [accessed 8 April
2020].
517 517
Table. Baseline characteristics of different pandemics.
developing countries. These types of infections are asymptomaticpeople which was testing positive for
caused by viruses or mixed viral–bacterial infections and SARS- CoV-2, varied between 5% and 80%4. In China, all
spread fast. The most of the primary mode of transmission clusters investigated and 78%–85% were within
of acute respiratory diseases is transmitted via droplets, families and secondary attack rate in household was
sometimes transmission occur through contact (including found 3%–10%5. Similar study was carried out in the US
hand contamination followed by self-inoculation) or and a symptomatic secondary attack rate for all
infectious respiratory aerosols at short distance3. household contacts among all contacts was found
The distribution and the outcome of epidemic varies 10.5% [19]. Household contacts and travelling with an
according to several factors such as household infected person increased the risk (OR:6-7). The
crowding, humidity, temperature, season, hygiene, household secondary attack rate was 15%, and the
access to health- care facilities, and isolation capacity, observed serial interval mean was 6.3 days. The median
demographic characteristics of population, cigarette- incubation period was 4.8 days (95% CI 4.2–5.4).
smoking, host ability to transmit infection, immune Symptoms were manifested within 14.0 days (95% CI
status, nutritional status, prevalence of comorbidity 12.2–15.9) of infection6. R0 was likely estimated to be 5.7
diseases, characteristics of pathogenic, modes of (
transmission, transmissibility, virulence factors, etc. 95% CI 3.8–8.9) in the US [20].
COVID-19 transmitted mainly through person to The overall case-fatality rate 2.3% and this rate was
person contact via respiratory droplet by coughing and 8.0% for aged 70–79 years and 14.8% for 80 years and
sneezing. Most of the cases were 30 to 79 years of age and older. Case-fatality rate was higher and varied between
the proportion was found 87%, under 19 years and 80 5.6% and 10.5% [18].
years or older were respectively 2% and 3% [18]. The COVID-19 pandemic is very similar to Spanish,
proportion of Hong Kong, Asian and swine influenza pandemics in
terms of spreading to world. Although countries were
suffered from
3
World Health Organization (2014). Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections
in healthcare [online]. Website https://apps.who.int/iris/bitstream/handle/10665/112656/9789241507134_eng.pdf ?sequence=1
[accessed
8 April
2020].
4
Centre for Evidence-Based Medicine (2020). COVID-19: what proportion are asymptomatic? [online]. Website
https://www.cebm.net/
covid-19/covid-19-what-proportion-are-asymptomatic/ [accessed 8 April
2020].
5
World HealthOrganization (2020). Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19) [online].
Website https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf [accessed 8
April 2020].
6
Bi Q, Wu Y, Mei S, Ye C, Zou X et al. (2020). Epidemiology and transmission of COVID-19 in Shenzhen China: analysis of
391 cases and 1,286 of their close contacts [online]. Website
https://www.medrxiv.org/content/10.1101/2020.03.03.20028423v3.article-info [accessed 8 April 2020].
4.
Conclusion
Burden of pandemic is considered in terms of disease
transmissibility and the rate of epidemic grows,
time of peaks, expected how many people to be
affected, and duration of pandemic can be calculated by
transmissibility characteristic. Hospitalization and
fatality are used as the indicators of the severity. At the
beginning of a pandemic, the characteristic of pandemic
agent is unknown. Therefore, surveillance method and
analyzing data should be planned in advance [21].
Consequently, determination of the first case cluster, case
definition and finding out cases, effective treatment to
the targeted population, sufficient stockpiles of
medicine and population cooperation with the
containment strategy and, in particular, any social
distance measures introduced should be considered for
reduction of burden of pandemic.
Figure. A pandemic is a threat for all globe (Source: Courtesy Acknowledgments/disclaimers/conflict of interest
of Levent AKIN is a member of COVID-19
Merve EVREN, PhD, Ege University). Advisory Committee of Ministry of Health of Turkey.
Mustafa Gökhan GÖZEL is a member of COVID-19
Advisory Committee of Ministry of Health of
References Turkey.
1. Potter CW. A history of influenza. Journal of Applied 7. Morens DM, Taubenberger JK, Fauci AS. The persistent
Microbiology legacy of the 1918 influenza virus. The New England
2001; 91 (4): 572-579. doi: 10.1046/j.1365-2672.2001.01492.x Journal of2009; 361 (3): 225-229. doi:
Medicine
2. Johnson N, Mueller J. Updating the accounts: global mortality 10.1056/NEJMp0904819
of the 1918–1920 “Spanish” influenza pandemic. Bulletin of 8.
the History of Medicine 2002; 76 (1): 105-115. doi: 10.1353/ Viboud C, Grais
Multinational RF, Lafont,
impact of HongBAP,
KongMiller MA, Simonsen
influenza L.
pandemic:
bhm.2002.0022 evidence for a smoldering pandemic. The Journal of Infectious
Diseases 2005; 192 (2): 233-249. doi: 10.1086/431150
3. Arda B, Acıduman A. Pandemic influenza 1918-19: lessons from
20th century to the 21st from the history of medicine point of 9. Jackson C, Vynnycky E, Mangtani P. Estimates of the
view. Lokman Hekim Journal 2012; 2 (3): 13-21. transmissibility of the 1968 (Hong Kong) influenza pandemic:
evidence of increased transmissibility between successive
4. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC et
waves. American Journal of Epidemiology 2010; 171 (4): 465-
al. Strategies for mitigating an influenza pandemic. Nature 2006;
442 (7101): 448-452. doi: 10.1038/nature04795 478. doi: 10.1093/aje/kwp394
5. Hsieh YC, Wu TZ, Liu DP, Shao PL, Chang LY et al. 10. Saunders-Hastings PR, Krewski D. Reviewing the history of
Influenza pandemics: past, present and future. Journal of the pandemic influenza: understanding patterns of emergence
Formosan Medical Association 2006; 105 (1): 1-6. doi: and transmission. Pathogens 2016; 5 (4): pii: 66. doi: 10.3390/
10.1016/S0929- pathogens5040066
6. Vynnycky E, Edmunds WJ. Analyses of the 1957 (Asian) 11. Reperant LA, Moesker FM, Osterhaus AD. Influenza: from
influenza pandemic in the United Kingdom and the impact of zoonosis to pandemic. ERJ Open Research 2016; 2 (1): 1-4. doi:
school closures. Epidemiology and Infection 2008; 136 (2): 166– 10.1183/23120541.00013-2016
179. doi:
10.1017/S0950268807008369
12. Nguyen-Van-Tam JS, Hampson AW. The epidemiology and 17. Viboud C, Simonsen L. Global mortality of 2009 pandemic
clinical impact of pandemic influenza. Vaccine 2003; 21 (16): influenza A H1N1. The Lancet Infectious Diseases 2012; 12 (9):
1762-1768. doi: 10.1016/s0264-410x(03)00069-0 651-653. doi: 10.1016/S1473-3099(12)70152-4
13. Henderson DA, Courtney B, Inglesby TV, Toner E, Nuzzo 18. Wu Z, McGoogan JM. Characteristics of and important lessons
JB. Public health and medical responses to the 1957-58 from the coronavirus disease 2019 (COVID-19) outbreak in
influenza pandemic. Biosecurity and Bioterrorism: Biodefense China summary of a report of 72 314 cases from the Chinese
Strategy, Practice, Science 2009; 7 (3): 265-273. doi: 10.1089/ Center for Disease Control and Prevention. JAMA 2020. doi:
bsp.2009.0729 10.1001/jama.2020.2648
14. Hall CB, Douglas RG Jr, Geiman JM, Meagher MP. Viral 19. Burke RM, Midgley CM, Dratch A, Fenstersheib M, Haupt T
shedding patterns of children with influenza B infection. The et al. Active monitoring of persons exposed to patients with
Journal of Infectious Diseases 1979; 140 (4): 610-613. doi: confirmed COVID-19–United States, January–February 2020.
10.1093/infdis/140.4.610 MMWR Morbidityand Mortality Weekly Report 2020; 69 (9):
245-246. doi: 10.15585/mmwr.mm6909e1
15. Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C
et al. Household Transmission of 2009 Pandemic Influenza 20. Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N et
A (H1N1) Virus in the United States The New England al. Contagiousness and rapid spread of severe acute respiratory
Journal of Medicine 2009; 361 (27): 2619-2627. doi: 10.1056/ syndrome Coronavirus 2. Emerging Infectious Diseases 2020;
NEJMoa0905498 26 (7). doi: 10.3201/eid2607.200282
16. Coburn BJ, Wagner BG, Blower S. Modeling influenza 21. Shearer FM, Moss R, McVernon J, Ross JV, McCaw JM.
epidemics and pandemics: insights into the future of swine flu Infectious disease pandemic planning and response:
(H1N1). BMC Medicine 2009; 7: 30. doi: 10.1186/1741-7015- incorporating decision analysis. PLoS Medicine 2020; 17 (1):
7-30 e1003018. doi: 10.1371/journal.pmed.1003018